Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H12N4O.ClH |
| Molecular Weight | 276.722 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C1CCC(=NN1)C2=CC=C(C=C2)N3C=CN=C3
InChI
InChIKey=BFIMZKOUNDYWCE-UHFFFAOYSA-N
InChI=1S/C13H12N4O.ClH/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17;/h1-4,7-9H,5-6H2,(H,16,18);1H
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex. | 2008-07-15 |
|
| Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model. | 2006-08 |
|
| Mechanisms of leptin secretion from white adipocytes. | 2002-07 |
|
| Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties. | 1993-06 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1715125
Patients were randomized to placebo or 2, 5 or 10 mg of imazodan administered twice daily.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
55917
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
89198-09-4
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
5EP74J9Q34
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
C72811
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
DTXSID40237570
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
CHEMBL12831
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
300000055147
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY | |||
|
W-96
Created by
admin on Mon Mar 31 17:56:23 GMT 2025 , Edited by admin on Mon Mar 31 17:56:23 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD